Paper35740554
Calcium Electroporation Reduces Viability and Proliferation Capacity of Four Uveal Melanoma Cell Lines in 2D and 3D Cultures.
Kraemer MM and 5 others. Cancers (Basel), 2022. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Calcium Electroporation Reduces Viability and Proliferation Capacity of Four Uveal Melanoma Cell Lines in 2D and 3D Cultures. Papers, record 35740554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35740554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Calcium Electroporation Reduces Viability and Proliferation Capacity of Four Uveal Melanoma Cell Lines in 2D and 3D Cultures.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2020-039, 21-030 | Dr. Rolf M. Schwiete Stiftung, Willy Robert Pitzer Stiftung | PubMed |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22815071 | Calcium and phosphatidylserine inhibit lipid electropore formation and reduce pore lifetime. | J Membr Biol | 2012 | https://conductscience.org/library/papers/22815071 | PubMed |
| 2 | 12680224 | Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin. | Anticancer Res | 2003 | https://conductscience.org/library/papers/12680224 | PubMed |
| 3 | 16401785 | The association between host susceptibility factors and uveal melanoma: a meta-analysis. | Arch Ophthalmol | 2006 | https://conductscience.org/library/papers/16401785 | PubMed |
| 4 | 24342489 | Calcium electroporation in three cell lines: a comparison of bleomycin and calcium, calcium compounds, and pulsing conditions. | Biochim Biophys Acta | 2014 | https://conductscience.org/library/papers/24342489 | PubMed |
| 5 | 28816072 | Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy. | Acta Oncol | 2018 | https://conductscience.org/library/papers/28816072 | PubMed |
| 6 | 18226859 | Targeted therapy for uveal melanoma. | Cancer Treat Rev | 2008 | https://conductscience.org/library/papers/18226859 | PubMed |
| 7 | 12838335 | Calcium signalling: dynamics, homeostasis and remodelling. | Nat Rev Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12838335 | PubMed |
| 8 | 31216772 | Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31216772 | PubMed |
| 9 | 7954463 | The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. | Cancer Res | 1994 | https://conductscience.org/library/papers/7954463 | PubMed |
| 10 | 16168056 | Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice. | BMC Cancer | 2005 | https://conductscience.org/library/papers/16168056 | PubMed |
| 11 | 11370791 | Generation, control, and processing of cellular calcium signals. | Crit Rev Biochem Mol Biol | 2001 | https://conductscience.org/library/papers/11370791 | PubMed |
| 12 | 26874618 | Applications of calcium electroporation to effective apoptosis induction in fibrosarcoma cells and stimulation of normal muscle cells. | Bioelectrochemistry | 2016 | https://conductscience.org/library/papers/26874618 | PubMed |
| 13 | 17435555 | Electrochemotherapy: aspects of preclinical development and early clinical experience. | Ann Surg | 2007 | https://conductscience.org/library/papers/17435555 | PubMed |
| 14 | 24970262 | Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma. | Invest Ophthalmol Vis Sci | 2014 | https://conductscience.org/library/papers/24970262 | PubMed |
| 15 | 18498012 | Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. | Ann Surg Oncol | 2008 | https://conductscience.org/library/papers/18498012 | PubMed |
| 16 | 28760856 | Normal and Malignant Cells Exhibit Differential Responses to Calcium Electroporation. | Cancer Res | 2017 | https://conductscience.org/library/papers/28760856 | PubMed |
| 17 | 21574833 | Management of cutaneous metastases using electrochemotherapy. | Acta Oncol | 2011 | https://conductscience.org/library/papers/21574833 | PubMed |
| 18 | 18083096 | Calcium signaling. | Cell | 2007 | https://conductscience.org/library/papers/18083096 | PubMed |
| 19 | 29534581 | Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro. | Neoplasma | 2018 | https://conductscience.org/library/papers/29534581 | PubMed |
| 20 | 19667335 | Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. | Arch Ophthalmol | 2009 | https://conductscience.org/library/papers/19667335 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42787544 | Custom bipolar electrode for bleomycin-based electrochemotherapy in patient-derived uveal melanoma in ovo and ex vivo. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42787544 | PubMed |
| 42088507 | Evaluation of unipolar and bipolar nanosecond pulses for calcium electrochemotherapy and immune response. | Front Immunol | 2026 | https://conductscience.org/library/papers/42088507 | PubMed |
| 40801007 | Power-Driven Electroporation Is Predictive of Treatment Outcomes in a Conductivity-Independent Manner. | BME Front | 2025 | https://conductscience.org/library/papers/40801007 | PubMed |
| 40733014 | Calcium Electrochemotherapy and Challenges in Combined Treatment with Dendritic Cell Vaccination. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40733014 | PubMed |
| 40014783 | Pulsed field ablation in medicine: irreversible electroporation and electropermeabilization theory and applications. | Radiol Oncol | 2025 | https://conductscience.org/library/papers/40014783 | PubMed |
| 39980072 | Calcium electroporation induces stress response through upregulation of HSP27, HSP70, aspartate β-hydroxylase, and CD133 in human colon cancer cells. | Biol Res | 2025 | https://conductscience.org/library/papers/39980072 | PubMed |
| 39065755 | Electroporation with Calcium or Bleomycin: First Application in an In Vivo Uveal Melanoma Patient-Derived Xenograft Model. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39065755 | PubMed |
| 38920653 | Recent Advances in Molecular and Genetic Research on Uveal Melanoma. | Cells | 2024 | https://conductscience.org/library/papers/38920653 | PubMed |
| 38256012 | Calcium Electroporation versus Electrochemotherapy with Bleomycin in an In Vivo CAM-Based Uveal Melanoma Xenograft Model. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38256012 | PubMed |
| 37630998 | Calcium Electrochemotherapy for Tumor Eradication and the Potential of High-Frequency Nanosecond Protocols. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37630998 | PubMed |
| 37522838 | Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy-Induced Necrosis. | Cancer Res | 2023 | https://conductscience.org/library/papers/37522838 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BAP1 | 8314 | PubTator's text mining | https://conductscience.org/library/genes/8314 | NCBI Gene |
| EIF1AX | 1964 | PubTator's text mining | https://conductscience.org/library/genes/1964 | NCBI Gene |
| GNA11 | 2767 | PubTator's text mining | https://conductscience.org/library/genes/2767 | NCBI Gene |
| GNAQ | 2776 | PubTator's text mining | https://conductscience.org/library/genes/2776 | NCBI Gene |
| MAP2K7 | 5609 | PubTator's text mining | https://conductscience.org/library/genes/5609 | NCBI Gene |
| PTEN | 5728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
| RB1 | 5925 | PubTator's text mining | https://conductscience.org/library/genes/5925 | NCBI Gene |
| SF3B1 | 23451 | PubTator's text mining | https://conductscience.org/library/genes/23451 | NCBI Gene |
| TERT | 7015 | PubTator's text mining | https://conductscience.org/library/genes/7015 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35740554
GET https://conductscience.org/api/papers/v1/35740554/references?page=2